Perbedaan Organon Pharma Indonesia Tbk. dan Tirta Mahakam Resources Tbk: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Tirta Mahakam Resources Tbk diperdagangkan di Rp590 (kapitalisasi pasar 657,65 M, volume 24 jam 520 rb). Perbedaan utamanya: Tirta Mahakam Resources Tbk jauh lebih besar — sekitar 6,3× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | TIRT | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 657,65 M |
Volume | — | 520 rb |
Lot | — | 5,2 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Tirta Mahakam Resources Tbk (The Company) was established based on Deed No. 245 dated April 22, 1981 jo. Revision deed No. 14 dated January 11, 1982, both of which were made in front of Notary Kartini Muljadi, SH. The Company started its commercial production in November 1983. The Companys domicilie is in South of Jakarta with its factories in Samarinda, East Kalimantan.
Selengkapnya di halaman TIRT →